Understanding and treating neurodegenerative diseases like Alzheimer's
Official title: Multimodal Delineation of Neurodegenerative Mechanisms
Funded at Yale University · NIH-10839862 · Data updated 2026-11-12
This study is all about helping new scientists learn how to understand Alzheimer's and related dementias better, so they can find new treatments that might improve the lives of patients living with these conditions.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $368,999 |
| NIH project number | 5T32NS131190-02 |
| Project ID | NIH-10839862 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals diagnosed with Alzheimer's Disease or related dementias.
✕Less likely to help
Patients with non-neurodegenerative conditions or those not diagnosed with dementia may not receive any benefit from this research.
What this research studies
This research focuses on training new scientists to explore the mechanisms behind Alzheimer's Disease and related dementias. By integrating various scientific disciplines such as cell biology, structural biology, and clinical medicine, the program aims to uncover the complexities of these conditions and their co-morbidities. Patients may benefit from the development of new, disease-modifying therapies that could improve their quality of life. The program involves collaboration among a diverse group of faculty and utilizes advanced resources, including specialized research centers.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that modify the progression of Alzheimer's Disease and related dementias.
How similar studies have gone: Previous research has shown promise in understanding neurodegenerative diseases through integrated approaches, indicating potential for success in this program.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Strittmatter, Stephen M — Yale University
- Study coordinator: Strittmatter, Stephen M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.